Pneumococcal Disease

Showing 1 - 25 of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide

Recruiting
  • Pneumococcal Disease
  • 23-valent pneumococcal polysaccharide vaccine
  • control pneumococcal polysaccharide vaccine
  • Chengdu, Sichuan, China
    Sichuan Center For Disease Control and Prevention
Sep 19, 2023

Pneumococcal Disease Trial (XJ103 Injection, Placebo)

Not yet recruiting
  • Pneumococcal Disease
  • XJ103 Injection
  • Placebo
  • (no location specified)
Sep 6, 2023

Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine)

Not yet recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • (no location specified)
May 16, 2023

Pneumococcal Disease Trial in Hialeah, Elkridge, San Antonio (Low dose multivalent pneumococcal conjugate vaccine formulation A,

Recruiting
  • Pneumococcal Disease
  • Low dose multivalent pneumococcal conjugate vaccine formulation A
  • +3 more
  • Hialeah, Florida
  • +2 more
Apr 27, 2023

Pneumococcal Disease Trial in Worldwide (V116, PPSV23)

Recruiting
  • Pneumococcal Disease
  • V116
  • PPSV23
  • Blacktown, New South Wales, Australia
  • +50 more
Jan 25, 2023

Pneumococcal Disease Trial in Japan (V116, PPSV23)

Recruiting
  • Pneumococcal Disease
  • V116
  • PPSV23
  • Osaka-shi, Osaka, Japan
  • +7 more
Jan 18, 2023

Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)

Recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • Budapest, Hungary
  • +33 more
Jan 11, 2023

Pneumococcal Disease Trial in India (13-valent pneumococcal conjugate vaccine)

Completed
  • Pneumococcal Disease
  • 13-valent pneumococcal conjugate vaccine
  • Surat, Gujarat, India
  • +4 more
Jan 10, 2023

Pneumococcal Disease Trial in Chile, United States (V116, Placebo, PCV15)

Active, not recruiting
  • Pneumococcal Disease
  • V116
  • +3 more
  • Phoenix, Arizona
  • +19 more
Dec 21, 2022

Pneumococcal Disease Trial in Japan, Korea, Republic of, Taiwan (20vPnC, Saline, 13vPnC)

Completed
  • Pneumococcal Disease
  • 20vPnC
  • +3 more
  • Itoshima, Fukuoka, Japan
  • +27 more
Dec 5, 2022

Pneumococcal Disease Trial in Worldwide (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)

Active, not recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • Nedlands, Western Australia, Australia
  • +63 more
Nov 3, 2022

Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)

Not yet recruiting
  • Pneumococcal Disease
  • 20-valent pneumococcal conjugate vaccine
  • 13-valent pneumococcal conjugate vaccine
  • (no location specified)
Aug 22, 2022

Pneumococcal Disease Trial in Worldwide (V116, PCV20)

Recruiting
  • Pneumococcal Disease
  • V116
  • PCV20
  • Birmingham, Alabama
  • +67 more
Aug 17, 2022

Pneumococcal Disease Trial in Korea, Republic of (V114)

Active, not recruiting
  • Pneumococcal Disease
  • V114
  • Jeonju-si, Jeonrabugdo, Korea, Republic of
  • +18 more
Aug 17, 2022

Pneumococcal Disease Trial (Candidate-1, Candidate-2, Candidate-3)

Not yet recruiting
  • Pneumococcal Disease
  • Candidate-1
  • +8 more
  • (no location specified)
Aug 3, 2022

Pneumococcal Disease Trial in United States (V116, PPSV23)

Not yet recruiting
  • Pneumococcal Disease
  • V116
  • PPSV23
  • (no location specified)
Jul 12, 2022

Pneumococcal Disease Trial in United States (Experimental 20-valent pneumococcal conjugate vaccine (20vPnC), Saline, Influenza

Completed
  • Pneumococcal Disease
  • Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Mobile, Alabama
  • +62 more
Jun 15, 2022

Healthy Volunteers, Pneumococcal Disease Trial in United States (ASP3772, PCV13)

Completed
  • Healthy Volunteers
  • Pneumococcal Disease
  • ASP3772
  • PCV13
  • Bryant, Arkansas
  • +16 more
Jun 2, 2022

Pneumococcal Disease Trial in United States (20vPnC)

Completed
  • Pneumococcal Disease
  • 20vPnC
  • Fayetteville, Arkansas
  • +41 more
May 24, 2022

Healthy Volunteers, Pneumococcal Disease Trial in United States (ASP3772, PCV13, PPSV23)

Completed
  • Healthy Volunteers
  • Pneumococcal Disease
  • ASP3772
  • +2 more
  • Banning, California
  • +25 more
Apr 27, 2022

Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),

Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
Mar 23, 2022

Pneumococcal Disease Trial in Sweden, United States (20vPnC, 13vPnC, PPSV23)

Completed
  • Pneumococcal Disease
  • 20vPnC
  • +3 more
  • Birmingham, Alabama
  • +67 more
Nov 29, 2021

Pneumococcal Disease Trial in Seoul (EuPCV15, Prevenar13)

Completed
  • Pneumococcal Disease
  • EuPCV15
  • Prevenar13
  • Seoul, Korea, Republic of
    The Catholic University of Seoul St.Mary's Hospital
Oct 6, 2021

Pneumococcal Disease Trial in Sweden, United States (13vPnC, PPSV23, 20vPnC)

Completed
  • Pneumococcal Disease
  • 13vPnC
  • +2 more
  • Mobile, Alabama
  • +41 more
Feb 2, 2021

Pneumococcal Disease Trial in United States (20vPnC, 13vPnC)

Completed
  • Pneumococcal Disease
  • 20vPnC
  • 13vPnC
  • Anaheim, California
  • +20 more
Nov 3, 2020